| Financial Year |
March 31 2023 |
| Monetary Funds |
442,648,477.32 |
| Held-for-trading Financial Assets |
9,300,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
264,093,570.08 |
| Advances to Suppliers |
60,790,616.96 |
| Other Receivables |
8,274,968.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
419,569,341.55 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,017.68 |
| Total Current Assets |
1,378,388,056.85 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
275,329,618.55 |
| Investment Properties |
23,475,306.80 |
| Fixed Assetes |
695,756,970.12 |
| Under-construction Projects |
5,372,319.32 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
51,777,117.48 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,869,441.23 |
| Deferred Income Tax Assets |
15,227,950.77 |
| Other Non-Current Assets |
9,379,438.07 |
| Sub-Total of Non-Current Assets |
1,134,488,324.73 |
| Total Assets |
2,512,876,381.58 |
| Short-Term Loans |
291,803,478.48 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,216,893.00 |
| Accounts Payable |
246,203,058.03 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
33,904,056.43 |
| Taxes Payable |
3,115,396.59 |
| Interest Payable |
293,265.07 |
| Dividend Payable |
-- |
| Other payables |
22,318,766.55 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
985,733.80 |
| Sub-Total of Current Liabilities |
636,527,575.88 |
| Long-term Loans |
192,669,719.39 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
392,362.96 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
261,081,726.90 |
| Total Liabilities |
897,609,302.78 |
| Paid-In Capital(Or Share Stock) |
267,883,579.00 |
| Capital Surplus |
976,366,618.10 |
| Surplus Reserve |
64,447,584.61 |
| LESS:Treasury Stock |
16,957,125.40 |
| Undistributed Profits |
322,104,090.04 |
| Minority Stockholder's Interest |
1,878,855.43 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,613,388,223.37 |
| Owner's Equity（Stockholder's Equity） |
1,615,267,078.80 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,512,876,381.58 |
